Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release shortage
To Be DiscontinuedDoxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.
Therapeutic category
Dosage form
Tablet
Routes
ORAL
Last updated
01/12/2026
Strength variants
- Not specified
Need sourcing help for Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Mylan Pharmaceuticals Inc., a Viatris Company800-796-9526To Be Discontinued
Reason for shortage
ad slot 300x250
Related shortages in Other
Sterile Water Injection
- Category
- Other
- Reason
- Not specified
- Updated
- 04/02/2026
Sterile Water Injection
- Category
- Other
- Reason
- Not specified
- Updated
- 04/02/2026
Sterile Water Injection
- Category
- Other
- Reason
- Not specified
- Updated
- 04/02/2026
Sterile Water Injection
- Category
- Other
- Reason
- Not specified
- Updated
- 04/02/2026
Sterile Water Injection
- Category
- Other
- Reason
- Not specified
- Updated
- 04/01/2026
Hydroxocobalamin Injection
- Category
- Other
- Reason
- Other
- Updated
- 04/01/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.